BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33009216)

  • 1. Value of Electroconvulsive Therapy in the General Public: A Willingness to Pay Study in Germany.
    Ulbrich L; Kröger C
    J ECT; 2021 Mar; 37(1):51-57. PubMed ID: 33009216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Willingness to pay for a quality-adjusted life year for depressive disorders compared to heart disease based on population preferences.
    Ulbrich L; Kröger C
    Qual Life Res; 2021 Jul; 30(7):1985-1995. PubMed ID: 33590463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zoster.
    Lieu TA; Ray GT; Ortega-Sanchez IR; Kleinman K; Rusinak D; Prosser LA
    Pharmacoeconomics; 2009; 27(12):1005-16. PubMed ID: 19908925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing preferences for prevention versus treatment using willingness to pay.
    Corso PS; Hammitt JK; Graham JD; Dicker RC; Goldie SJ
    Med Decis Making; 2002; 22(5 Suppl):S92-101. PubMed ID: 12369235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monetary Valuation of a Quality-Adjusted Life Year (QALY) for Depressive Disorders Among Patients and Non-Patient Respondents: A Matched Willingness to Pay Study.
    Ulbrich L; Kröger C
    Clin Psychol Eur; 2021 Dec; 3(4):e3855. PubMed ID: 36398289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Willingness to pay for a National Health Insurance Scheme in The Gambia: a contingent valuation study.
    Njie H; Wangen KR; Chola L; Gopinathan U; Mdala I; Sundby JS; Ilboudo PGC
    Health Policy Plan; 2023 Jan; 38(1):61-73. PubMed ID: 36300926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Willingness to pay for an mRNA-based anti-cancer treatment: results from a contingent valuation study in Israel.
    Ben-Aharon O; Sergienko R; Iskrov G; Greenberg D
    Isr J Health Policy Res; 2024 Feb; 13(1):9. PubMed ID: 38374060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Willingness to pay for a cure of low-risk melanoma patients in Germany.
    Augustin M; Blome C; Forschner A; Gutzmer R; Hauschild A; Heinzerling L; Livingstone E; Loquai C; Schadendorf D; Utikal J; Wagner T; Wilden S; Kähler KC
    PLoS One; 2018; 13(5):e0197780. PubMed ID: 29795621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining Willingness-to-Pay and Zero Valuations for a Health Improvement with Logistic Regression.
    Mavrodi AG; Chatzopoulos SA; Aletras VH
    Inquiry; 2021; 58():469580211028102. PubMed ID: 34271848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Jumping the Queue:Willingness to Pay for Faster Access to COVID-19 Vaccines in Seven European Countries.
    Neumann-Böhme S; Sabat I; Brinkmann C; Attema AE; Stargardt T; Schreyögg J; Brouwer W
    Pharmacoeconomics; 2023 Oct; 41(10):1389-1402. PubMed ID: 37344725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community acceptance and willingness-to-pay for a hypothetical Zika vaccine: A cross-sectional study in Indonesia.
    Harapan H; Mudatsir M; Yufika A; Nawawi Y; Wahyuniati N; Anwar S; Yusri F; Haryanti N; Wijayanti NP; Rizal R; Fitriani D; Maulida NF; Syahriza M; Ikram I; Fandoko TP; Syahadah M; Asrizal FW; Aletta A; Jamil KF; Rajamoorthy Y; Hadisoemarto PF; Wagner AL; Groneberg DA; Kuch U; Sasmono RT; Müller R; Imrie A
    Vaccine; 2019 Mar; 37(11):1398-1406. PubMed ID: 30739794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-benefit of cholinesterase inhibitors in mild to moderate dementia: a willingness-to-pay approach.
    Wu G; Lanctôt KL; Herrmann N; Moosa S; Oh PI
    CNS Drugs; 2003; 17(14):1045-57. PubMed ID: 14594444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Willingness to Pay for National Health Insurance: A Contingent Valuation Study Among Patients Visiting Public Hospitals in Melaka, Malaysia.
    Tan RTH; Abdul Rasid SZ; Wan Ismail WK; Tobechan J; Tan ETY; Yusof AN; Low JH
    Appl Health Econ Health Policy; 2022 Mar; 20(2):255-267. PubMed ID: 34927225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients' willingness to pay for the treatment of tuberculosis in Nigeria: exploring own use and altruism.
    Ochonma OG; Onwujekwe OE
    Int J Equity Health; 2017 May; 16(1):74. PubMed ID: 28486981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Willingness to Pay in Caregivers of Patients Affected by Schizophrenia.
    Daltio CS; Attux C; Ferraz MB
    J Ment Health Policy Econ; 2017 Mar; 20(1):3-10. PubMed ID: 28418833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health professionals' acceptance and willingness to pay for hepatitis B virus vaccination in Gondar City Administration governmental health institutions, Northwest Ethiopia.
    Abiye S; Yitayal M; Abere G; Adimasu A
    BMC Health Serv Res; 2019 Nov; 19(1):796. PubMed ID: 31690313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge and attitudes on electroconvulsive therapy in Germany: A web based survey.
    Wilhelmy S; Rolfes V; Grözinger M; Chikere Y; Schöttle S; Groß D
    Psychiatry Res; 2018 Apr; 262():407-412. PubMed ID: 28923432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Willingness to pay for maternal health outcomes: are women willing to pay more than men?
    Ternent L; McNamee P; Newlands D; Belemsaga D; Gbangou A; Cross S
    Appl Health Econ Health Policy; 2010; 8(2):99-109. PubMed ID: 20067333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The willingness to pay for in vitro fertilization: a pilot study using contingent valuation.
    Neumann PJ; Johannesson M
    Med Care; 1994 Jul; 32(7):686-99. PubMed ID: 8028404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Willingness to pay for obesity treatment.
    Narbro K; Sjöström L
    Int J Technol Assess Health Care; 2000; 16(1):50-9. PubMed ID: 10815353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.